Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Clopidogrel
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Antiplatelet medicines
- ATC
- B01AC
- Strength
- 300 mg
- Dosage form
- Tablet
- Pack
- 10's
- Registration no.
- 062870
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
CCL Pharmaceuticals (Pvt.) Limited
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Noclot-LD 300 (Clopidogrel) is used for
Clopidogrel is an antiplatelet medicine, often called a blood thinner. Platelets are tiny blood cells that stick together to plug a cut. Clopidogrel makes them less sticky, so harmful clots are less likely to form inside narrowed or hardened blood vessels. This lowers the chance of a heart attack or stroke. It comes as tablets and is a prescription medicine. A doctor may give it on its own, together with low-dose aspirin, or in place of aspirin.
- Lowering the risk of another heart attack or stroke in people who have already had one
- After unstable angina (severe chest pain) or a heart attack
- After a stroke, or a mini-stroke (TIA)
- Peripheral arterial disease (poor blood flow to the legs)
- Hardening and narrowing of the arteries (atherosclerosis)
- After a heart or blood vessel procedure, such as having a stent put into a heart artery
Get medical help straight away if
- Get emergency help for coughing up blood, vomiting blood, or vomit that looks like coffee grounds.
- Get emergency help for a nosebleed that will not stop.
- Get emergency help for a sudden, severe headache, especially with confusion, slurred speech, weakness or numbness in an arm or leg, or changes in sight. This can be a sign of bleeding in the brain.
- Get medical help straight away if you hit your head while taking clopidogrel, because of the risk of bleeding inside the head.
Side effects, warnings and interactions for Clopidogrel
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Clopidogrel
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Clopidogrel is right for you and the dose.
- Stroke: started within 24 hours of an ischaemic stroke once bleeding is ruled out, and straight away for a TIA
About Noclot-LD 300 300 mg tablet
Noclot-LD 300 300 mg tablet contains Clopidogrel 300 mg. It is registered with DRAP by CCL Pharmaceuticals (Pvt.) Limited (registration no. 062870). Its official price is PKR 711.91 for a pack of 10's, about PKR 71.19 per tablet. This price has applied since 23 July 2026. It is sold in 2 pack sizes: 1's and 10's. 9 other brands of Clopidogrel 300 mg (tablet) are registered in Pakistan. Compare all brands and prices →
Noclot-LD 300 300 mg pack sizes and prices
| Pack | Official price | Per tablet |
|---|---|---|
| 1's | PKR 71.19 | — |
| 10's (this page) | PKR 711.91 | PKR 71.19 |
All 9 other brands of Clopidogrel 300 mg tablet in Pakistan
These 9 brands are alternatives (substitutes) to Noclot-LD 300: each contains Clopidogrel 300 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is Cloevo (Evolution Pharmaceuticals (Pvt.) Ltd) at PKR 51.02 per tablet; the highest is Plavix at PKR 71.19. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Cloevo | Evolution Pharmaceuticals (Pvt.) Ltd | 10's | PKR 510.23 | PKR 51.02 / tablet |
| Grelcar-DS | Health care pharmaceuticals | 10’s | PKR 516.22 | PKR 51.62 / tablet |
| Clopinext | Next Pharmaceutical Products (Pvt.) Ltd | 10's | PKR 566.02 | PKR 56.60 / tablet |
| Revive Pro | Scotmann Pharmaceuticals | 10's | PKR 627.84 | PKR 62.78 / tablet |
| FLEXIFLOW | Wilshire Laboratories (Private) Limited | 10's | PKR 638.44 | PKR 63.84 / tablet |
| Ogrel | Bosch Pharmaceuticals (Pvt) Ltd | 10's | PKR 660.11 | PKR 66.01 / tablet |
| Norplat | Scilife Pharma Private Limited | 10's | PKR 670.18 | PKR 67.02 / tablet |
| Lowplat | PHARMEVO (PVT) LTD | 1x2's | PKR 142.38 | PKR 71.19 / tablet |
| Plavix | Hoechst Pakistan Limited | 4's | PKR 284.77 | PKR 71.19 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Noclot-LD 300, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- CCL Pharmaceuticals (Pvt.) Limited, Lahore
- DRAP registration
- 062870
- Phone
- +92 42 111 225 678
- Website
- https://cclpharma.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (10's). Current price PKR 711.91, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Noclot-LD 300 300 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/noclot-ld-300-300-mg-062870-1s-ccl-pharmaceuticals-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 711.91 | 2026-07-23 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 062870Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.